Concepedia

Author

Nadja E. Schoemaker

The Netherlands Cancer Institute

Also Known As

N E Schoemaker, N Schoemaker, N. SCHOEMAKER, Nadja E Schoemaker, Nadja E. Schoemaker, Nadja Schoemaker

13

Publications

310

Citations

9

H-Index

21

Concepts

All Affiliations

The Netherlands Cancer InstituteSlotervaartziekenhuisUtrecht UniversityNerviano Medical Sciences
NE

About

Nadja E. Schoemaker is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

118

2

Pharmacology

4

4

85

3

Biochemistry

2

2

37

4

Natural Sciences

1

1

25

5

Pathology

1

1

33

Nadja E. Schoemaker

×

9

Publications

296

Citations

9

H-Index

YearCitations

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin

Nadja E. Schoemaker, Charlotte van Kesteren, Hilde Rosing,

British Journal of Cancer

2002

119

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

Nadja E. Schoemaker, I. E. L. M. Kuppens, Vladimir Moiseyenko,

British Journal of Cancer

2004

34

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

Virginie M.M. Herben, Nadja E. Schoemaker, Hilde Rosing,

Cancer Chemotherapy and Pharmacology

2002

33

Phase I study of an oral formulation of irinotecan administered daily for 14�days every 3�weeks in patients with advanced solid tumours

Nadja E. Schoemaker, I. E. L. M. Kuppens, W.W. ten Bokkel Huinink,

Cancer Chemotherapy and Pharmacology

2004

29

High-Performance Liquid Chromatographic Analysis of the Anticancer Drug Irinotecan (CPT-11) and Its Active Metabolite SN-38 in Human Plasma

Nadja E. Schoemaker, Hilde Rosing, S Jansen,

Therapeutic Drug Monitoring

2003

25

Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule

Nadja E. Schoemaker, Ron A. Math�t, Patrick Sch�ffski,

Cancer Chemotherapy and Pharmacology

2002

19

Phase I and Pharmacokinetic Study of a Daily Times 5 Short Intravenous Infusion Schedule of 9-Aminocamptothecin in a Colloidal Dispersion Formulation in Patients With Advanced Solid Tumors

Virginie M.M. Herben, R. van Gijn, Jan H.M. Schellens,

Journal of Clinical Oncology

1999

13

High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma

Nadja E. Schoemaker, E. Frigerio, Daniela Fraier,

Journal of Chromatography B Biomedical Sciences and Applications

2001

12

Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

Mirjam Crul, Nadja E. Schoemaker, Dick Pluim,

PubMed

2003

12

Page 1